Isak Im
Impact in
- Geriatrics and Gerontology top 10%
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Sirtuins and Resveratrol in Medicine 2
-
- Signaling Pathways in Disease 2
- Receptor Mechanisms and Signaling 2
- Co-authors
- Yong‐Chul Kim (11 shared papers)Jae‐Il Kim (2 shared papers)Yun Pyo Kang (1 shared paper)Sangjun Park (1 shared paper)Je‐Wook Yu (1 shared paper)Yong‐Keun Jung (2 shared papers)Eunju Lee (1 shared paper)Wonsuk Yang (1 shared paper)
- Journals
- ChemBioChem (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)European Journal of Medicinal Chemistry (2 papers)Journal of the American Chemical Society (1 paper)Molecules and Cells (1 paper)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Isak Im
15 papers receiving 571 citations
Peers
Comparison fields: 5 of 77
- Geriatrics and Gerontology 30
- Neurology 58
- Organic Chemistry 158
- Physiology 22
- Molecular Biology 300
Countries citing papers authored by Isak Im
This map shows the geographic impact of Isak Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isak Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isak Im more than expected).
Fields of papers citing papers by Isak Im
This network shows the impact of papers produced by Isak Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isak Im. The network helps show where Isak Im may publish in the future.
Co-authors
The 25 scholars most cited alongside Isak Im, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 138 | |
| 2 | 2013 | 118 | |
| 3 | 2010 | 88 | |
| 4 | 2005 | 36 | |
| 5 | 2014 | 33 | |
| 6 | 2009 | 30 | |
| 7 | 2010 | 30 | |
| 8 | 2004 | 27 | |
| 9 | 2009 | 22 | |
| 10 | 2007 | 21 | |
| 11 | 2011 | 19 | |
| 12 | 2004 | 14 | |
| 13 | 2009 | 12 | |
| 14 | 2012 | 6 | |
| 15 | 2012 | 1 | |
| 16 | 2011 | 0 |
About Isak Im
Isak Im is a scholar working on Geriatrics and Gerontology, Molecular Biology, Oncology, Organic Chemistry and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 595 indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (3 papers), Computational Drug Discovery Methods (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Viral Infections and Immunology Research (2 papers), Signaling Pathways in Disease (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Receptor Mechanisms and Signaling (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Geriatrics and Gerontology (30 citations), Neurology (58 citations), Organic Chemistry (158 citations), Physiology (22 citations) and Molecular Biology (300 citations). Isak Im has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Yong‐Chul Kim, Jae‐Il Kim, Yun Pyo Kang, Sangjun Park, Je‐Wook Yu, Yong‐Keun Jung, Eunju Lee, Wonsuk Yang, Jiho Jang and So‐Deok Lee. Their work appears in journals such as ChemBioChem, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Journal of the American Chemical Society and Molecules and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.